ABVC BioPharma Inc (ABVC)
1.07
+0.01
(+0.94%)
USD |
NASDAQ |
May 17, 16:00
1.05
-0.02
(-1.87%)
After-Hours: 20:00
ABVC BioPharma Total Liabilities (Quarterly): 6.362M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.362M |
| September 30, 2023 | 7.530M |
| June 30, 2023 | 9.687M |
| March 31, 2023 | 9.000M |
| December 31, 2022 | 6.343M |
| September 30, 2022 | 4.787M |
| June 30, 2022 | 4.602M |
| March 31, 2022 | 4.705M |
| December 31, 2021 | 4.828M |
| September 30, 2021 | 4.765M |
| June 30, 2021 | 8.429M |
| March 31, 2021 | 8.797M |
| December 31, 2020 | 8.945M |
| September 30, 2020 | 7.721M |
| June 30, 2020 | 7.876M |
| March 31, 2020 | 7.838M |
| December 31, 2019 | 7.053M |
| September 30, 2019 | 6.675M |
| June 30, 2019 | 10.28M |
| March 31, 2019 | 12.98M |
| December 31, 2018 | 5.846M |
| September 30, 2018 | 5.043M |
| June 30, 2018 | 4.887M |
| March 31, 2018 | 4.489M |
| December 31, 2017 | 4.400M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.148M |
| June 30, 2017 | 1.056M |
| March 31, 2017 | 1.029M |
| December 31, 2016 | 6.538M |
| September 30, 2016 | 6.556M |
| June 30, 2016 | 2.061M |
| March 31, 2016 | 0.0057M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.3691M |
| June 30, 2015 | 0.0374M |
| March 31, 2015 | 0.0359M |
| December 31, 2014 | 0.0351M |
| September 30, 2014 | 0.034M |
| June 30, 2014 | 2.112M |
| March 31, 2014 | 2.112M |
| December 31, 2013 | 2.112M |
| September 30, 2013 | 2.112M |
| June 30, 2013 | 2.112M |
| March 31, 2013 | 2.092M |
| December 31, 2012 | 2.073M |
| September 30, 2012 | 1.946M |
| June 30, 2012 | 1.828M |
| March 31, 2012 | 1.675M |
| December 31, 2011 | 1.678M |
| September 30, 2011 | 1.833M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.602M
Minimum
Jun 2022
10.28M
Maximum
Jun 2019
7.170M
Average
7.530M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 9.485M |
| Sutro Biopharma Inc | 305.38M |
| Reviva Pharmaceuticals Holdings Inc | 14.84M |
| Flora Growth Corp | 17.22M |
| Journey Medical Corp | 53.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.49M |
| Shareholders Equity (Quarterly) | 8.388M |
| Debt to Equity Ratio | 0.1751 |
| Current Ratio | 0.2793 |
| Net Debt Paydown Yield | 0.87% |